The campers at Camp Kemo have or had cancer or blood disorders however they are not away from their family completely. Campers get to bring as many of their siblings as they want free of cost. The ...
Neoadjuvant or adjuvant chemotherapy confers a modest benefit over surgery alone for resectable non–small-cell lung cancer (NSCLC). In early-phase trials, nivolumab-based neoadjuvant regimens have ...
The GIMEMA ALL2820 trial showed Iclusig plus Blincyto outperformed Gleevec plus chemotherapy in Ph-positive ALL patients, with higher complete hematologic response rates and fewer deaths. The ...
Patients with radiologically staged T3-4, N0-2, M0 colon cancer were randomly allocated (2:1) to 6 weeks oxaliplatin-fluoropyrimidine preoperatively plus 18 postoperatively (NAC group) or 24 weeks ...
In an interim analysis of this phase 3 trial, the addition of pembrolizumab to chemotherapy resulted in longer progression-free survival than chemotherapy alone among patients with advanced ...
The approval was based on data from a phase 3 POSEIDON study. The Food and Drug Administration (FDA) has approved Imjudo (tremelimumab-actl) in combination with Imfinzi (durvalumab) and platinum-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback